Pharmacogenetics and Genomics

Papers
(The H4-Index of Pharmacogenetics and Genomics is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-1966
Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study24
PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics23
Identification of populations likely to benefit from pharmacogenomic testing15
Knowledge, attitude, and practice towards pharmacogenomics among hospital pharmacists in Thailand15
Association of SLCO1B1 c.521T>C (rs4149056) with discontinuation of atorvastatin due to statin-associated muscle symptoms14
Association between polymorphisms in the vitamin D receptor and susceptibility to multiple sclerosis13
Cost-effectiveness analysis of pretreatment screening for NUDT15 defective alleles11
Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry10
A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators10
0.016517162322998